-
SPOTLIGHT
We are proud to announce that Dr. David Alland, chief of infectious diseases at NJMS, has been named the inaugural director for the new Center for COVID-19 Response and Pandemic Preparedness to address SARS CoV-2 and other emerging pathogen threats.
Read more -
SPOTLIGHT
Dr. William Gause and Dean Johnson toured i3D research laboratories in the NJMS Cancer Center with Senators Bob Menendez and Cory Booker
Faculty, including Drs. Karen Edelblum, Amariliz Rivera, and Mark Siracusa discussed their research programs and the importance of NIH funded biomedical research for the development of new and effective treatments and therapeutics at i3D, ranging from anti-infectives to targeted regulators of immunity. Read more -
SPOTLIGHT
Dr. William Gause and Dean Johnson toured i3D research laboratories in the NJMS Cancer Center with Senators Bob Menendez and Cory Booker
Faculty, including Drs. Karen Edelblum, Amariliz Rivera, and Mark Siracusa discussed their research programs and the importance of NIH funded biomedical research for the development of new and effective treatments and therapeutics at i3D, ranging from anti-infectives to targeted regulators of immunity. Read more -
SPOTLIGHT
Dr. William Gause and Dean Johnson toured i3D research laboratories in the NJMS Cancer Center with Senators Bob Menendez and Cory Booker
Faculty, including Drs. Karen Edelblum, Amariliz Rivera, and Mark Siracusa discussed their research programs and the importance of NIH funded biomedical research for the development of new and effective treatments and therapeutics at i3D, ranging from anti-infectives to targeted regulators of immunity. Read more -
SPOTLIGHT
Dr. William Gause and Dean Johnson toured i3D research laboratories in the NJMS Cancer Center with Senators Bob Menendez and Cory Booker
Faculty, including Drs. Karen Edelblum, Amariliz Rivera, and Mark Siracusa discussed their research programs and the importance of NIH funded biomedical research for the development of new and effective treatments and therapeutics at i3D, ranging from anti-infectives to targeted regulators of immunity. Read more -
SPOTLIGHT
Dr. William Gause and Dean Johnson toured i3D research laboratories in the NJMS Cancer Center with Senators Bob Menendez and Cory Booker
Faculty, including Drs. Karen Edelblum, Amariliz Rivera, and Mark Siracusa discussed their research programs and the importance of NIH funded biomedical research for the development of new and effective treatments and therapeutics at i3D, ranging from anti-infectives to targeted regulators of immunity. Read more -
FEATURED
Rapid Ebola Test Is Focus of NIH Grant to Rutgers Scientist
David Alland, Professor of Medicine and Associate Dean for Clinical Research at Rutgers New Jersey Medical School – and the principal investigator for the project – says health workers would be able to take the test to small villages and other remote locations where the spread of Ebola has been especially rampant and diagnose patients where they live. Read more -
FEATURED
Dr. Fitzgerald-Bocarsly
Dr. Fitzgerald-Bocarsly, Professor of Pathology and Laboratory Medicine, Scientific Director of the NJMS Flow Cytometry Core Laboratory, and member of the NJMS Center for Immunity and Inflammation.
Breaking the Poverty-Disease Cycle
Dysfunction of the immune system is increasingly recognized as contributing to a broad spectrum of infectious and noninfectious diseases. The specific focus of our new institute provides a unique opportunity to build an innovative and significant program of biomedical research excellence for Newark and the State of New Jersey. It provides the opportunity to develop innovative perspectives and insights for the development of new treatments and diagnostics that can be rapidly translated to the clinic.
READ MORE
ABOUT I³D
